• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Apollo to retool imaging portfolio

Article

Investment firm Apollo Management is restructuring its holdings in the imaging services segment by arranging to have its Alliance Imaging unit acquire SMT Health Services, another mobile imaging provider that Apollo owns. Alliance of Anaheim, CA,

Investment firm Apollo Management is restructuring its holdings in the imaging services segment by arranging to have its Alliance Imaging unit acquire SMT Health Services, another mobile imaging provider that Apollo owns. Alliance of Anaheim, CA, announced on April 15 that it will acquire Pittsburgh-based SMT in a stock-for-stock merger in which Alliance will assume responsibility for $68.4 million in SMT debt.

New York City-based Apollo has been intent on consolidating the mobile imaging segment, and bought SMT in 1997 and Alliance in 1998 (SCAN 7/9/97 and 1/14/98). Apollo originally operated the two firms as separate entities in order to maintain Alliance’s favorable tax status, but apparently now sees advantages to running them both under Alliance’s umbrella. Following the acquisition, Alliance will operate about 285 MRI scanners across the U.S. Alliance executives were not available for comment on the deal.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.